Alpha 2.0
Login Register
» Articles » PMID: 2417079

In-vitro Inhibition of LAV/HTLV-III Infected Lymphocytes by Dithiocarb and Inosine Pranobex

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1985 Dec 21
PMID 2417079
Citations 5
Authors
A Pompidou
D Zagury
R C Gallo
D Sun
A Thornton
P S SARIN
Affiliations
Soon will be listed here.
Citing Articles

Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.

De Simone C, Albertini F, Almaviva M, Angarano G, Chiodo F, Costigliola P Med Oncol Tumor Pharmacother. 1989; 6(1):63-7.

PMID: 2471025 DOI: 10.1007/BF02985225.

Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1.

Schinazi R, Cannon D, ARNOLD B Antimicrob Agents Chemother. 1988; 32(12):1784-7.

PMID: 2469387 PMC: 176018. DOI: 10.1128/AAC.32.12.1784.

Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Sorkin E, Heel R Drugs. 1986; 32(5):383-424.

PMID: 2431857 DOI: 10.2165/00003495-198632050-00001.

Antiviral strategies and vaccines against HTLV III/LAV.

Dalgleish A J R Coll Physicians Lond. 1986; 20(4):258-67.

PMID: 2430099 PMC: 5371046.

Treatment of the acquired immune deficiency syndrome.

Gupta S, Gottlieb M J Clin Immunol. 1986; 6(3):183-93.

PMID: 2424929 DOI: 10.1007/BF00918698.